Baid Finserv Limited (NSE:BAIDFIN)

CTI BioPharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	134.46	129.24	103.79	87.87	74.8
Depreciation & Amortization	-	7.3	4.13	3.28	2.86	2.9
Other Amortization	-	-	0.7	-	-	-
Change in Accounts Payable	-	-3.28	11.22	-12.49	0.8	-4.93
Change in Other Net Operating Assets	-	-416.49	-602.59	-215.06	38.64	190.93
Other Operating Activities	-	303.21	243.59	175.22	209.74	241.5
Operating Cash Flow	-	19.28	-217.72	55.34	339.99	504.82
Operating Cash Flow Growth	-	-	-	-83.72%	-32.65%	26.10%
Capital Expenditures	-	-15.95	-31.9	-3.07	-2.97	-2.93
Sale (Purchase) of Intangibles	-	-1.1	-0.97	-0.42	-	-0.07
Other Investing Activities	-	0.26	-0.01	0.11	-0.29	-0.9
Investing Cash Flow	-	-61.54	-15.86	28.11	-55.76	4.01
Long-Term Debt Issued	-	135.03	711.46	109.44	-	-
Total Debt Issued	-	135.03	711.46	109.44	-	-
Long-Term Debt Repaid	-	-	-	-	-41.35	-246.93
Total Debt Repaid	-	-	-	-	-41.35	-246.93
Net Debt Issued (Repaid)	-	135.03	711.46	109.44	-41.35	-246.93
Common Dividends Paid	-	-12.01	-12.01	-12.01	-6	-
Other Financing Activities	-	-293.37	-230.05	-176.72	-195.35	-239.87
Financing Cash Flow	-	-170.35	469.4	-79.29	-242.69	-486.79
Net Cash Flow	-	-212.6	235.81	4.15	41.53	22.04
Free Cash Flow	-	3.33	-249.62	52.27	337.02	501.89
Free Cash Flow Growth	-	-	-	-84.49%	-32.85%	25.37%
Free Cash Flow Margin	-	0.65%	-63.58%	16.88%	127.57%	187.76%
Free Cash Flow Per Share	-	0.03	-2.08	0.49	2.81	4.18
Cash Interest Paid	-	293.41	230.55	176.75	196.01	240.57
Cash Income Tax Paid	-	46.91	51.73	36.11	33.65	28.1

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.